Sign in to continue:

Wednesday, May 6th, 2026

RTX Corporation 8-K Filing Details for 2.150% Notes Due 2030 on NYSE – Company Information & Key Disclosures

RTX Corporation 2026 Annual Meeting: Shareholder Update and Voting Results

RTX Corporation Provides Results of 2026 Annual Meeting of Shareowners

RTX Corporation (NYSE: RTX) has released the results of its 2026 Annual Meeting of Shareowners, which took place on April 30, 2026. The meeting addressed several critical matters, including the election of directors, executive compensation, and the appointment of the company’s independent auditor for 2026. Below is a comprehensive summary of the key developments and their potential implications for investors.

Key Highlights from the Annual Meeting

  • Date of Meeting: April 30, 2026
  • Record Date: March 3, 2026
  • Total Outstanding Shares: 1,345,974,220
  • Shares Present or Represented (Quorum): 1,194,489,831

1. Election of Directors

Shareholders voted on the election of directors for a term expiring at the 2027 Annual Meeting, or until their successors are elected and qualified. All nominees listed in the proxy statement were elected. While the report does not list the individual directors or vote totals by name, the affirmation of all nominees signals continued support for RTX’s current leadership and strategic direction.

2. Advisory Vote on Executive Compensation (“Say-on-Pay”)

A key item on the agenda was the advisory vote to approve the compensation of RTX’s named executive officers. The results were as follows:

  • Votes For: 1,006,669,958
  • Votes Against: 35,108,448
  • Abstentions: 4,157,853
  • Broker Non-Votes: 148,553,572

The overwhelming “For” vote (over 96%) reflects strong shareholder approval of the company’s executive pay practices. This is an important signal to the market and may be viewed positively by investors as it suggests alignment between management and shareholder interests.

3. Appointment of Independent Auditor

The meeting included a proposal to appoint PricewaterhouseCoopers LLP (PwC) as the company’s independent registered public accounting firm for 2026, until the next annual meeting in 2027. The proposal was approved by a majority of shareholders, confirming continued confidence in PwC’s oversight of RTX’s financial reporting.

Summary of Securities Listed

RTX Corporation’s principal securities registered under Section 12(b) of the Securities Exchange Act include:

  • Common Stock (\$1 par value) – Trading Symbol: RTX – Listed on the New York Stock Exchange (NYSE) (CUSIP: 75513E 101)
  • 2.150% Notes due 2030 – Trading Symbol: RTX 30 – Listed on the NYSE (CUSIP: 75513E AB7)

Other Notable Disclosures

  • RTX Corporation is not classified as an “emerging growth company” under current SEC definitions.
  • No written communications, soliciting materials, or pre-commencement tender offers were filed or are relevant for this meeting.

Potential Price Sensitive Information

None of the matters voted upon at the meeting represent a significant change in corporate direction, governance, or financial structure. All routine items—director elections, executive compensation, and auditor ratification—were approved by wide margins, signaling stability and continued shareholder support. There are no new material disclosures or actions that would be expected to significantly move the RTX share price in the short term.

Conclusion for Investors

RTX Corporation’s 2026 Annual Meeting concluded with all management proposals approved by substantial majorities. The company’s leadership team and executive compensation remain backed by shareholders, and PwC will continue as auditor. These outcomes should reassure investors regarding RTX’s corporate governance and stability. However, as there were no unexpected developments or controversial issues, the meeting results are unlikely to drive significant share price movement at this time.


Disclaimer: This article is provided for informational purposes only and does not constitute investment advice. Investors are encouraged to review the official SEC filings and consult their financial advisors before making any investment decisions. The author and publisher accept no liability for actions taken based on the information contained herein.


View RTX Corp Historical chart here



ADC Therapeutics SA Reports Q1 2026 Financial Results and Updates – NYSE: ADCT

ADC Therapeutics Q1 2026 Financial Report: Detailed Investor...

   Ad

Join Our Investing Seminar

Limited seats available — Reserve your spot today